{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:31:12Z","timestamp":1791261072443,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12936-015-0708-1","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T16:27:37Z","timestamp":1431534457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Development of two novel high-throughput assays to quantify ubiquitylated proteins in cell lysates: application to screening of new anti-malarials"],"prefix":"10.1186","volume":"14","author":[{"given":"Lydia","family":"Mata-Cantero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Cid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G","family":"Gomez-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Xolalpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Aillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Julio","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel S","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"key":"708_CR1","first-page":"13","volume":"2014","author":"M Schmidt","year":"1843","unstructured":"Schmidt M, Finley D. Regulation of proteasome activity in health and disease. Biochem Biophys Acta. 1843;2014:13\u201325.","journal-title":"Biochem Biophys Acta"},{"key":"708_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1042\/BST0370937","volume":"37","author":"D Komander","year":"2009","unstructured":"Komander D. The emerging complexity of protein ubiquitination. Biochem Soc Trans. 2009;37:937\u201353.","journal-title":"Biochem Soc Trans"},{"key":"708_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.tcb.2010.03.007","volume":"20","author":"L Bedford","year":"2010","unstructured":"Bedford L, Paine S, Sheppard PW, Mayer RJ, Roelofs J. Assembly, structure, and function for the 26S proteasome. Trends Cell Biol. 2010;20:391\u2013401.","journal-title":"Trends Cell Biol"},{"key":"708_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1074-5521(01)00056-4","volume":"8","author":"AF Kisselev","year":"2001","unstructured":"Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates. Chem Biol. 2001;8:739\u201358.","journal-title":"Chem Biol"},{"key":"708_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.chembiol.2012.01.003","volume":"19","author":"AF Kisselev","year":"2012","unstructured":"Kisselev AF, Van der Linden WA, Overkleeft HS. Proteasome inhibitors: an expanding army attacking a unique target. Chem Biol. 2012;19:99\u2013115.","journal-title":"Chem Biol"},{"key":"708_CR6","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.2174\/1381612811319220014","volume":"19","author":"W Xolalpa","year":"2013","unstructured":"Xolalpa W, Perez-Galan P, Rodriguez MS, Roue G. Targeting the ubiquitin proteasome system: beyond proteasome inhibition. Curr Pharm Des. 2013;19:4053\u201393.","journal-title":"Curr Pharm Des"},{"key":"708_CR7","series-title":"\u201cStress Response Pathways in Cancer: From Molecular Targets to Novel Therapeutics\u201d Editor: Georg Thomas Wondrak, Ph.D. Springer Science Books","first-page":"223","volume-title":"The ubiquitin-proteasome system (UPS) as a cancer drug target: emerging mechanisms and therapeutics","author":"L Mata-Cantero","year":"2014","unstructured":"Mata-Cantero L, Lobato-Gil S, Aillet F, Lang V, Rodriguez MS. The ubiquitin-proteasome system (UPS) as a cancer drug target: emerging mechanisms and therapeutics, \u201cStress Response Pathways in Cancer: From Molecular Targets to Novel Therapeutics\u201d Editor: Georg Thomas Wondrak, Ph.D. Springer Science Books, vol. 11. 2014. p. 223\u201363."},{"key":"708_CR8","first-page":"1","volume":"2","author":"MN Aminake","year":"2012","unstructured":"Aminake MN, Arndt HD, Pradel G. The proteasome of malaria parasites: A multi-stage drug target for chemotherapeutic intervention? Int J Parasitol. 2012;2:1\u201310.","journal-title":"Int J Parasitol"},{"key":"708_CR9","doi-asserted-by":"publisher","first-page":"40320","DOI":"10.1074\/jbc.M111.238790","volume":"286","author":"N Ponts","year":"2011","unstructured":"Ponts N, Saraf A, Chung DWD, Harris A, Prudhomme J, Washburn MP, et al. Unravelling the human malaria parasite\u2019s ubiquitome. J Biol Chem. 2011;286:40320\u201330.","journal-title":"J Biol Chem"},{"key":"708_CR10","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.chembiol.2012.09.019","volume":"19","author":"H Li","year":"2012","unstructured":"Li H, Ponder EL, Verdoes M, Asbjornsdottir KH, Deu E, Edgington LE, et al. Validation of the proteasome as a therapeutic target in Plasmodium using an epoxiketone inhibitor with parasite-specific toxicity. Chem Biol. 2012;19:1535\u201345.","journal-title":"Chem Biol"},{"key":"708_CR11","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1021\/cb5001263","volume":"9","author":"H Li","year":"2014","unstructured":"Li H, van der Linden WA, Verdoes M, Florea BI, McAllister FE, Govindaswamy K, et al. Assessing subunit dependency of the Plasmodium proteasome using small molecule inhibitors and active site probes. ACS Chem Biol. 2014;9:1869\u201376.","journal-title":"ACS Chem Biol"},{"key":"708_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1039\/c3mb70506d","volume":"10","author":"MJ Hamilton","year":"2014","unstructured":"Hamilton MJ, Lee M, Le Roch KG. The ubiquitin system: an essential component to unlocking the secrets of malaria parasite biology. Mol BioSyst. 2014;10:715\u201323.","journal-title":"Mol BioSyst"},{"key":"708_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1472-6904-7-13","volume":"7","author":"JM Reynolds","year":"2007","unstructured":"Reynolds JM, El Bissati K, Brandenburg J, G\u00fcnzl A, Mamoun CB. Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B. BMC Clin Pharmacol. 2007;7:13.","journal-title":"BMC Clin Pharmacol"},{"key":"708_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1475-2875-7-187","volume":"7","author":"A Kreidenweiss","year":"2008","unstructured":"Kreidenweiss A, Kremsner PG, Mordm\u00fcller G. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon. Malar J. 2008;7:187.","journal-title":"Malar J"},{"key":"708_CR15","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1128\/AAC.42.10.2731","volume":"42","author":"SM Gantt","year":"1998","unstructured":"Gantt SM, Myung JM, Briones MRS, Li WD, Corey EJ, Omura S, et al. Proteasome inhibitors block development of Plasmodium spp. Antimicrob Agents Chemother. 1998;42:2731\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"708_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/187152610791163345","volume":"10","author":"DWD Chung","year":"2010","unstructured":"Chung DWD, Le Roch KG. Targeting the Plasmodium ubiquitin\/proteasome system with anti-malarial compounds: promises for the future. Infect Disord Drug Targets. 2010;10:158\u201364.","journal-title":"Infect Disord Drug Targets"},{"key":"708_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12013-013-9621-9","volume":"67","author":"AT Melvin","year":"2013","unstructured":"Melvin AT, Woss GS, Park JH, Waters ML, Allbritton NL. Measuring activity in the ubiquitin-proteasome system: from large scale discoveries to single cells analysis. Cell Biochem Biophys. 2013;67:75\u201389.","journal-title":"Cell Biochem Biophys"},{"key":"708_CR18","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.leukres.2010.07.003","volume":"34","author":"A Liggett","year":"2010","unstructured":"Liggett A, Crawford LJ, Walker B, Morris TCM, Irvine AE. Methods for measuring proteasome activity: Current limitations and future developments. Leuk Res. 2010;34:1403\u20139.","journal-title":"Leuk Res"},{"key":"708_CR19","first-page":"26","volume":"2014","author":"ML Stein","year":"1843","unstructured":"Stein ML, Groll M. Applied techniques for mining natural proteasome inhibitors. Biochem Biophys Acta. 1843;2014:26\u201338.","journal-title":"Biochem Biophys Acta"},{"key":"708_CR20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0076-6879(05)98030-0","volume":"398","author":"A Kisselev","year":"2005","unstructured":"Kisselev A, Goldberg A, Deshaies R. Monitoring activity and inhibition of 26S proteasome with fluorogenic peptide substrates. Methods Enzymol. 2005;398:364\u201378.","journal-title":"Methods Enzymol"},{"key":"708_CR21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0076-6879(05)98033-6","volume":"398","author":"M Hoyt","year":"2005","unstructured":"Hoyt M, Zhang M, Coffino P, Deshaies R. Probing the ubiquitin\/proteasome system with ornithine decarboxylase, a ubiquitin-independent substrate. Methods Enzymol. 2005;398:399\u2013413.","journal-title":"Methods Enzymol"},{"key":"708_CR22","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1046\/j.1471-4159.1994.63041578.x","volume":"63","author":"ME Figueiredo-Pereira","year":"1994","unstructured":"Figueiredo-Pereira ME, Berg KA, Wilk S. A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell. J Neurochem. 1994;63:1578\u201381.","journal-title":"J Neurochem"},{"key":"708_CR23","first-page":"2094","volume":"2012","author":"JG Marblestone","year":"1823","unstructured":"Marblestone JG, La Rocque JP, Mattern MR, Leach CA. Analysis of ubiquitin E3 ligase activity using selective polyubiquitin binding proteins. Biochem Biophys Acta. 1823;2012:2094\u20137.","journal-title":"Biochem Biophys Acta"},{"key":"708_CR24","first-page":"2038","volume":"2012","author":"S Schneider","year":"1823","unstructured":"Schneider S, Chen H, Tang J, Emkey R, Andrews PS. Development of a homogeneous Alphalisa ubiquitination assay using ubiquitin binding matrices as universal components for the detection of ubiquitylated proteins. Biochem Biophys Acta. 1823;2012:2038\u201345.","journal-title":"Biochem Biophys Acta"},{"key":"708_CR25","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/embor.2009.192","volume":"10","author":"R Hjerpe","year":"2009","unstructured":"Hjerpe R, Aillet F, Lopitz-Otsoa F, Lang V, England P, Rodriguez MS. Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep. 2009;10:1250\u20138.","journal-title":"EMBO Rep"},{"key":"708_CR26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-1-61779-474-2_12","volume":"832","author":"F Aillet","year":"2012","unstructured":"Aillet F, Lopitz-Otsoa F, Hjerpe R, Torres-Ramos M, Lang V, Rodr\u00edguez MS. Isolation of ubiquitylated proteins using Tandem Ubiquitin- Binding Entities (TUBEs). Methods Mol Biol. 2012;832:173\u201383.","journal-title":"Methods Mol Biol"},{"key":"708_CR27","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1016\/j.jprot.2011.12.001","volume":"75","author":"F Lopitz-Otsoa","year":"2012","unstructured":"Lopitz-Otsoa F, Rodriguez-Suarez E, Aillet F, Casado-Vela J, Lang V, Matthiesen R, et al. Integrative analysis of the ubiquitin proteome isolated using Tandem Ubiquitin Binding Entities. J Proteomics. 2012;75:2998\u20133014.","journal-title":"J Proteomics"},{"key":"708_CR28","unstructured":"Research and Reference Reagent Resource Center (MR4). http:\/\/www.mr4.org."},{"key":"708_CR29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"13","author":"W Trager","year":"1976","unstructured":"Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;13:673\u20135.","journal-title":"Science"},{"key":"708_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1475-2875-13-112","volume":"13","author":"L Mata-Cantero","year":"2014","unstructured":"Mata-Cantero L, La Fuente MJ, Sanz L, Rodriguez MS. Magnetic isolation of Plasmodium falciparum schizonts iRBCs to generate a high parasitaemia and synchronized in vitro culture. Malar J. 2014;13:112.","journal-title":"Malar J"},{"key":"708_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","volume":"465","author":"FJ Gamo","year":"2010","unstructured":"Gamo FJ, Sanz LM, Vidal J, De Cozar C, Alvarez E, Lavandera JL, et al. Thousands of chemical starting points for antimalarial lead identification. Nature. 2010;465:305\u201310.","journal-title":"Nature"},{"key":"708_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nature09099","volume":"465","author":"WA Guiguemde","year":"2010","unstructured":"Guiguemde WA, Shelat AA, Bouck D, Duffy S, Crowther GJ, Davis PH, et al. Chemical genetics of Plasmodium falciparum. Nature. 2010;465:11\u2013315.","journal-title":"Nature"},{"key":"708_CR33","doi-asserted-by":"publisher","first-page":"9059","DOI":"10.1073\/pnas.0802982105","volume":"105","author":"D Plouffe","year":"2008","unstructured":"Plouffe D, Brinker A, McNamara C, Henson K, Kato N, Kuhen K, et al. In silico activity profiling reveals the mechanism of action of antimalarial discovered in a high throughput screen. Proc Natl Acad Sci USA. 2008;105:9059\u201364.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0708-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-015-0708-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0708-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0708-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T14:02:33Z","timestamp":1630591353000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-015-0708-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1186\/s12936-015-0708-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,14]]},"assertion":[{"value":"29 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"200"}}